Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

1. Invesco Gold & Special Minerals Fund A USD Acc

  • Security

    Invesco Gold & Special Minerals Fund A USD Acc

  • Fee

    2.00%

  • ISIN

    LU0505655562

  • Holdings

    7

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 11 holdings in Invesco Gold & Special Minerals Fund A USD Acc, where the largest holding is Northern Star Resources (4.93), followed by Agnico Eagle Mines (3.84) and Newmont (3.8). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Invesco Gold & Special Minerals Fund A USD Acc and UBS Lux Equity Fund Biotech USD.

Invesco Gold & Special Minerals Fund A USD Acc UBS Lux Equity Fund Biotech USD
1. Northern Star Resources Ltd
Australia
4.93 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Agnico Eagle Mines Ltd
Canada
3.84 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Newmont Corp
USA
3.8 %
3. Moderna Inc
9.21 %
4. Artemis Gold Inc
Canada
3.24 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. K92 Mining Inc
Canada
3.21 %
5. AbbVie Inc
USA
5.53 %
6. Kinross Gold Corp
Canada
3.1 %
6. Gilead Sciences Inc
USA
4.66 %
7. Gold Fields ADR
South Africa
2.96 %
7. Amgen Inc
4.3 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 6, 2025.